Generic Name: Denosumab (Drug Plan Submission)
Brand Name: Xgeva
Manufacturer: Amgen Canada Inc.
Indications: Prevention of skeletal-related events due to bone metastases from other solid tumors (excluding breast and prostate cancer), including non-small cell lung cancer
Submission Type: Drug Plan Initiated
Project Status: Complete
Date Recommendation Issued: March 23, 2016
Recommendation Type: List with clinical criteria and/or conditions